Effect of asiaticoside on 99mTc-tetrofosmin and 99mTc-sestamibi uptake in MCF-7 cells

Journal of Nuclear Medicine Technology

Volumn 39, Issue 4, 2011, Pages 279-283

  Al Saeedi, Fatma J ^a   Bitar, Milad ^a   Pariyani, Smitha ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

99mTc sestamibi; 99mTc tetrofosmin; Asiaticoside; MCF 7 cells

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ASIATICOSIDE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TETROFOSMIN TC 99M; TRACER; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE; TRITERPENE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL VIABILITY; DOSE RESPONSE; DRUG EFFECT; DRUG UPTAKE; HUMAN; HUMAN CELL; RADIOACTIVITY; BREAST TUMOR; COMPARATIVE STUDY; METABOLIC CLEARANCE RATE; METABOLISM; SCINTISCANNING; TUMOR CELL LINE;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; METABOLIC CLEARANCE RATE; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TRITERPENES;

EID: 84855576770     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnmt.111.091868     Document Type: Article

References (36)

1. 99mTc-MIBI SPECT: MRI validation of the EXINI heart software package. Clin Physiol Funct Imaging. 2009;29:89-94.
2. 99mTc-sestamibi to monitor treatment with antisense oligodeoxynucleotide complementary to MRP mRNA in human breast cancer cells. Ann Nucl Med. 2006;20:29-34.
3. 99mTc-MIBI uptake in breast cancer cell lines. Eur J Nucl Med Mol Imaging. 2004;31:521-527.
4. Myoview [package insert]. Arlington Heights, IL: Amersham-US; 1996.
5. Jain D, Wackers FJ, Mattera J, McMahon M, Sinusas AJ, Zaret BL. Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent-implications for a one-day imaging protocol. J Nucl Med. 1993;34:1254-1259.
6. 99mTc-Q12 into human breast cancer cell lines. Eur J Nucl Med. 1996;23:1361-1366.
7. Higley B, Smith FW, Smith T, et al. Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med. 1993;34:30-38.
8. Lind P, Gallowitsch HJ, Langsteger W, Kresnik E, Mikosch P, Gomez I. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma. J Nucl Med. 1997;38:348-352.
9. Fenlon HM, Phelan NC, Sullivan P, Tierney S, Gorey T, Ennis JT. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography. Radiology. 1997;205:214-220.
10. Soler C, Beauchesne P, Maatougui K, et al. Technetium-99m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy. Eur J Nucl Med. 1998;25:1649-1657.
11. 18F-fluorodeoxyglucose. J Neurooncol. 2000;46:63-70.
12. Beauchesne P, Soler C, Mosnier JF. Diffuse vertebral body metastasis from a glioblastoma multiforme: a technetium-99m sestamibi single-photon emission computerized tomography study. J Neurosurg. 2000;93:887-890.
13. Söderlund V, Jonsson C, Bauer HC, Brosjö O, Jacobsson H. Comparison of technetium-99m-MIBI and technetium-99m-tetrofosmin uptake by musculoskeletal sarcomas. J Nucl Med. 1997;38:682-686.
14. 99mTc-tetrofosmin into malignant versus nonmalignant breast cell lines. J Nucl Med. 2000;41:1495-1499.
15. Arbab AS, Koizumi K, Toyama K, Arai T, Araki T. Technetium-99m-tetrofosmin, technetium-99m-MIBI, and thallium-201 uptake in rat myocardial cells. J Nucl Med. 1998;39:266-271.
16. 99mTc-MIBI. Nucl Med Commun. 2001;22:807-811.
17. UK cancer incidence statistics by age. Cancer Research UK Web page. Available at: http://info.cancerresearchuk.org/cancerstats/incidence/age/. Published January 2007. Accessed October 19, 2011.
18. World Health Organization. Cancer. Available at: http://www.who.int/mediacentre/factsheets/fs297/en/. Published February 2006. Accessed June 25, 2007.
19. Dunham W. Report sees 7.6 million global 2007 cancer deaths. Reuters Web site. Available at: http://www.reuters.com/article/2007/12/17/us-cancer-world-idUSN1633064920071217. Published December 2007. Accessed October 19, 2011.
20. Lakshmi B, Ajith TA, Jose N, Janardhanan KK. Antimutagenic activity of methanolic extract of Ganoderma lucidum and its effect on hepatic damage caused by benzo[a]pyrene. J Ethnopharmacol. 2006;107:297-303.
21. Gao J, Huang F, Zhang J, Zhu G, Yang M, Xiao P. Cytotoxic cycloartane triterpene saponins from Actaea asiatica. J Nat Prod. 2006;69:1500-1502.
22. Huang YH, Zhang SH, Zhen RX, Xu XD, Zhen YS. Asiaticoside inducing apoptosis of tumor cells and enhancing anti-tumor activity of vincristine. Ai Zheng. 2004;23:1599-1604.
23. Jang DS, Lee GY, Kim J, et al. A new pancreatic lipase inhibitor isolated from the roots of Actinidia arguta. Arch Pharm Res. 2008;31:666-670.
24. Mook-Jung I, Shin JE, Yun SH, et al. Protective effects of asiaticoside derivatives against beta-amyloid neurotoxicity. J Neurosci Res. 1999;58:417-425.
25. Arbab AS, Koizumi K, Toyama K, Araki T. Uptake of Tc-99m-tetrofosmin, Tc-99m-MIBI, and TI-201 in tumor cell lines. J Nucl Med. 1996;37:1551-1556.
26. Arbab AS, Koizumi K, Toyama K, Arai T, Araki T. Ion transport systems in the uptake of Tc-99m-tetrofosmin, Tc-99m-MIBI and TI-201 in a tumor cell line. Nucl Med Commun. 1997;18:235-240.
27. Blankenberg FG, Strauss HW. Noninvasive strategies to image cardiovascular apoptosis. Cardiol Clin. 2001;19:165-172.
28. Gurfinkel DM, Chow S, Hurren R, et al. Disruption of the endoplasmic reticulum and increases in cytoplasmic calcium are early events in cell death induced by the natural triterpenoid asiatic acid. Apoptosis. 2006;11:1463-1471.
29. Gnanapragasam A, Yogeeta S, Subhashini R, Ebenezar KK, Sathish V, Devaki T. Adriamycin induced myocardial failure in rats: protective role of Centella asiatica. Mol Cell Biochem. 2007;294:55-63.
30. Babu TD, Kuttan G, Padikkala J. Cytotoxic and anti-tumour properties of certain taxa of Umbelliferae with special reference to Centella asiatica (L.) Urban. J Ethnopharmacol. 1995;48:53-57.
31. Hendrikse NH, Franssen EJ, van der Graaf WT, Vaalburg W, de Vries EG. Visualization of multidrug resistance in vivo. Eur J Nucl Med. 1999;26:283-293.
32. Zheng LH, Bao YL, Wub Y, Yu CL, Meng XY, Li YX. Cantharidin reverses multidrug resistance of human hepatoma HepG2/ADM cells via down-regulation of P-glycoprotein expression. Cancer Lett. 2008;272:102-109.
33. Bonte F, Dumas M, Chaudagne C, Meybeck A. Influence of asiatic acid, madecassic acid, and asiaticoside on human collagen I synthesis. Planta Med. 1994; 60:133-135.
34. Park BC, Bosire KO, Lee ES, Lee YS, Kim JA. Asiatic acid induces apoptosis in SK-MEL-2 human melanoma cells. Cancer Lett. 2005;218:81-90.
35. 2+ release and enhanced expression of p53 in HepG2 human hepatoma cells. Cancer Lett. 2002;186:83-91.
36. Gao J, Chen J, Tang X, et al. Mechanism underlying mitochondrial protection of asiatic acid against hepatotoxicity in mice. J Pharm Pharmacol. 2006;58:227-233.